Drug intelligence / Profile preview

rutin

Development stage
Phase 4
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Rutin is a naturally occurring flavonoid glycoside found in many plants such as buckwheat, Japanese pagoda tree (Sophora japonica), and Eucalyptus macrorhyncha. It is commonly used as an over-the-counter dietary supplement and has been studied for its potential therapeutic effects on capillary fragility, blood flow improvement, reduction of blood clots risk, arthritis pain relief, and neuroprotection. Rutin exhibits antioxidant and anti-inflammatory properties and has shown promise in preclinical studies for conditions like Alzheimer's disease due to its ability to reduce oxidative stress and ß-amyloid oligomers. Mechanistically, it acts primarily as an antioxidant scavenging free radicals; it also modulates various cellular transporters involved in renal function and inhibits inflammatory pathways such as the NOD-like receptor three inflammasome[1][3][5].

Brand names
TibrolinSTERIHEAL DISPERSIBLE
Other names
rutosidequercetin-3-O-rutinosidequercetin3-O-rutinosidequercetin 3-O-rutinosidesophorinvitamin P
02

Targets

NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)RdRp (Coronavirus RNA-dependent RNA polymerase)Mpro (3C-like proteinase of SARS-CoV-2)PLpro (Papain-like protease)GSEC (Gamma-Secretase Complex)

Beyond the preview

Go deeper on rutin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rutin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call